Clinical Trials Sponsored by AstraZeneca

Total 4285 results

AstraZeneca

Completed

An Epidemiological Study to Evaluate Standard Daily Practice in Managing Patients With Arterial Hypertension

Hypertension

Serbia
AstraZeneca

Terminated

Patient's Anastrozole Compliance to Therapy Programme (PACT)

Breast Cancer
AstraZeneca

Completed

Symbicort Turbuhaler 30/60 Clinical Experience Investigation (SURE)

Bronchial Asthma

Japan
AstraZeneca

Completed

The Performance of Patient Support Program in Early Stage Breast Cancer (ARI NIS)

Breast Cancer

China
AstraZeneca

Completed

Reasons for Changing HOrmonal Therapy of Advanced Breast Cancer (HOT ABC)

Breast Cancer

Czech Republic
AstraZeneca

Completed

Study of the Efficacy and Safety of Quetiapine Fumarate Extended Release (Seroquel XR) (QUENCH)

Schizophrenia

Korea, Republic of
AstraZeneca

Completed

To Assess the Safety, Tolerability and Pharmacokinetics of AZD2820 After Single Ascending Doses

Healthy

United Kingdom
AstraZeneca

Completed

A Study of Single and Multiple Ascending Doses of TC-5214 in Japanese Healthy Elderly Male and Female Volunteers

Healthy

Japan
AstraZeneca

Completed

Dyslipaemia, Atherosclerosis Risk and Increased hsCRP and Inflammatory and Oxidative Status in the Spanish Population. Database Analysis of Previous Studies Performed in Spain (DARIOS)

Dyslipaemia | Atherosclerosis Risk | Increased hsCRP | Inflammatory and Oxidative Status in the Spanish Population

Spain
AstraZeneca

Completed

An Interaction Study to Evaluate the Effect of Esomeprazole/Acetylsalicylic Acid on the Metabolism and Effect of Clopidogrel

Healthy Volunteers

Sweden
AstraZeneca

Completed

Multicentre Study to Explore the Correlation Between Smoking Pattern and Clinical Efficacy of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Male Patients

Non Small Cell Lung Cancer

Taiwan
AstraZeneca

Completed

Cardiac Electrophysiological Study

Atrial Flutter

Finland, Norway, Denmark, Sweden
AstraZeneca

Completed

Effect of Crestor (Rosuvastatin) on Lipid Levels in Patients With Metabolic Syndrome (EFFORT)

Metabolic Syndrome

Turkey
AstraZeneca

Completed

A Diabetes Study to Treat A Population Previously Not at Target (ADAPT)

Type 2 Diabetes

Canada
AstraZeneca

Terminated

ARMOR (Analyzing Renal Mechanisms of Creatinine Excretion in Patients On tesaglitazaR)

Diabetes Mellitus, Type 2

United States
AstraZeneca

Withdrawn

AZD8075 Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Oral Doses of AZD8075 in Healthy Male Volunteers

Healthy
AstraZeneca

Completed

Single and Multiple Ascending Dose Study for NKTR-118 and Cross-over Study to Investigate the Effect of Food for NKTR-118 in Japanese Healthy Subjects (Japan SMAD)

Healthy

Japan
AstraZeneca

Completed

To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC) (PIONEER)

Non Small Cell Lung Cancer

Vietnam, Philippines, China, Hong Kong, Taiwan, Thailand, India
AstraZeneca

Completed

Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD4451 (AZD4451 SAD)

Bipolar Disorder

United States
AstraZeneca

Completed

Effects of Administration of Fostamatinib on Blood Concentrations of Rifampicin in Healthy Subjects.

Rheumatoid Arthritis | Healthy Volunteers

United States
AstraZeneca

Completed

Cross-sectional Study to Investigate the Effects of Chronic Obstructive Pulmonary Disease on Daily Life Activities (COPD LIFE)

Chronic Obstructive Pulmonary Disease

Turkey
AstraZeneca

Completed

An Epidemiological Study to Describe Symptom Control and Impact of Gastroesophageal Reflux Disease

GERD

Serbia
AstraZeneca

Completed

Study to Characterize the Long-term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years (Hypertension in Pediatrics) (HIP)

Hypertension

France, Germany, Poland, Ukraine, Belgium, Italy
AstraZeneca

Completed

The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours

Schizophrenia | Major Depressive Disorders | Bipolar Disorders
AstraZeneca

Completed

An Observational Study of Adherence to Anastrozole in Early Breast Cancer Treatment

Breast Cancer

Vietnam
AstraZeneca

Completed

Study to Assess the Safety and Tolerability of AZD1152 in Combination With Low Dose Cytosine Arabinoside (LDAC)

Acute Myeloid Leukemia

United States, France
AstraZeneca

Completed

A Study of Fostamatinib in Subjects With Impaired Kidney Function

Rheumatoid Arthritis | Renal Impairment

United States
AstraZeneca

Completed

A Study to Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May Experience

Gastroesophageal Reflux Disease

United States
AstraZeneca

Withdrawn

Gastroprotective Agent Utilization and Compliance in Patients > 60 Years Taking Low-dose Aspirin in France

Self-administered Questionnaire to Patients
AstraZeneca

Completed

APOLLO(Aromatase Inhibitor Patient cOmpLiance Program With qoL Questionaire) (APOLLO)

Breast Cancer

Korea, Republic of
AstraZeneca

Completed

AURORA: Crestor 10mg Versus Placebo in Subjects With End-stage Renal Disease (ESRD)

Renal Failure

Sweden, Bulgaria, Czech Republic, France, Poland, United Kingdom, Germany, Hungary, Finland, Netherlands, Norway, Canada, Mexico, Australia, Austria, Belgium, Denmark, Greece, Italy, Iceland, Brazil, Switzerland, Ireland, Korea, Republic... and more
AstraZeneca

Terminated

To Evaluate Effects of AZD1446, Placebo and Donepezil in Patients With Alzheimer's Disease

Alzheimer´s Disease

Russian Federation, Ukraine
AstraZeneca

Completed

To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Administration of AZD8329 (AZ8329)

Healthy | Overweight | Male

United Kingdom
AstraZeneca

Withdrawn

Dyslipidemia Treatment in Thailand and Cardiovascular Outcomes (DEMAND)

Dyslipidemia
AstraZeneca

Completed

A Cross-sectional Study on the Prevalence and Extraesophageal Symptoms of Gastroesophageal Reflux Disease(GERD) in Patients With Upper GI Symptoms, Visiting the Outpatient Departments of Peripheral Hospitals in Greece (GERDQ-XS)

Gastroesophageal Reflux Disease

Greece
AstraZeneca

Completed

Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours

Advanced Solid Tumors

Denmark, Canada
AstraZeneca

Completed

A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) Treatment (KOSMOS)

COPD | Chronic Diseases

Denmark
AstraZeneca

Terminated

AZD7325 Japan Multiple Ascending Dose (MAD) Study (JMAD)

Healthy
AstraZeneca

Completed

Nis Register Study Comparing Seroquel and Seroquel Prolong

Comparing Hospitalisation Time With Seroquel and Seroquel Prolong

Finland
AstraZeneca

Completed

To Evaluate the Effect of AZD3199 on the Electrical Activity in the Heart

Chronic Obstructive Pulmonary Disease | Lung Disease

United Kingdom
AstraZeneca

Terminated

Phase I Single Ascending Dose/Multiple Ascending Dose in Patients Treated With AZD7762 and Irinotecan

Cancer | Advanced Solid Tumors | Advanced Solid Malignancies

United States
AstraZeneca

Withdrawn

A Study of ZD1839 Effects on Cell Proliferation in Breast Cancer

Breast Cancer

Italy
AstraZeneca

Completed

Study to Investigate Daily Symptom Variability, Symptom Effects on Morning Activities of Chronic Obstructive Disease

Chronic Obstructive Pulmonary Disease

Turkey
AstraZeneca

Completed

An Observational Study to Investigate How Patients Experience the Ability to Adjust Their Asthma Maintenance Medication (INVOLVE)

Asthma
AstraZeneca

Completed

Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 mg in Patients With Prostate Cancer

Prostate Cancer

Italy
AstraZeneca

Completed

ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck Cancer

Head and Neck Cancer

Spain
AstraZeneca

Completed

Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression

Bipolar Disorder | Depression, Bipolar

United States
AstraZeneca

Suspended

Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)

Kidney Neoplasms | Carcinoma, Renal Cell

United States
AstraZeneca

Completed

Combination Casodex® and Iressa™ in Locally Advanced Prostate Cancer

Locally Advanced Prostate Cancer

Norway
AstraZeneca

Completed

Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Alternative)

Congestive Heart Failure

3

Subscribe